biotech
biotech Articles
AnaptysBio is easily one of the best performing stocks on Tuesday, with its shares jumping over 70% in this session.
Published:
Last Updated:
24/7 Wall St. has collected a few more catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Last Updated:
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.
Published:
Last Updated:
ImmunoGen saw its shares make a sharp turn downward on Thursday morning after the stock has seen an incredible year of trading so far.
Published:
Last Updated:
CytomX Therapeutics shares made a solid gain in Wednesday’s session following announcement of a strategic collaboration with Amgen in immuno-oncology.
Published:
Last Updated:
Amicus Therapeutics is another biotech player seeing a nice boost from the World Muscle Society Conference in France.
Published:
Last Updated:
Catabasis Pharmaceuticals shares continued their incredible climb after the announcement of positive efficacy results from its MoveDMD trial in a late-breaking session at the World Muscle Society...
Published:
Last Updated:
U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. But this part of the market has not come without controversy in the past year and a half.
Published:
Last Updated:
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) saw its shares make a handy gain on Monday after the firm received an upgrade from Morgan Stanley. The driving force behind this upgrade is Sarepta’s...
Published:
Last Updated:
Endocyte kicked off the week with an incredible gain, making it one of the best, if not the best, performing stocks in Monday’s session.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up in October for biotech and pharmaceutical companies.
Published:
Zogenix saw its shares more than double early on Friday after the company reported positive top-line results from its most recent late-stage trial in the treatment of Dravet syndrome.
Published:
Last Updated:
AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen.
Published:
Last Updated:
The September 15 short interest data have been compared with the previous report, and short interest in all the selected biotech stocks increased.
Published:
Last Updated:
If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's disease.
Published:
Last Updated: